Elham Hatami
Impact in
-
- Tannin, Tannase and Anticancer Activities
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Cancer, Lipids, and Metabolism 3
- MicroRNA in disease regulation 2
-
- Nanoparticle-Based Drug Delivery 4
- Co-authors
- Murali Mohan Yallapu (13 shared papers)Subhash C. Chauhan (12 shared papers)Meena Jaggi (11 shared papers)Prashanth K.B. Nagesh (10 shared papers)Pallabita Chowdhury (8 shared papers)Bilal Bin Hafeez (3 shared papers)Sheema Khan (3 shared papers)Vivek Kumar Kashyap (4 shared papers)
- Journals
- Pharmaceutics (2 papers)Cancers (2 papers)ACS Applied Materials & Interfaces (1 paper)ACS Biomaterials Science & Engineering (1 paper)Cells (1 paper)
- Partner nations
- United StatesIran
In The Last Decade
Elham Hatami
18 papers receiving 691 citations
Peers
Comparison fields: 5 of 88
- Applied Microbiology and Biotechnology 41
- Biomaterials 158
- Molecular Medicine 47
- Pharmaceutical Science 49
- Biochemistry 42
Countries citing papers authored by Elham Hatami
This map shows the geographic impact of Elham Hatami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elham Hatami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elham Hatami more than expected).
Fields of papers citing papers by Elham Hatami
This network shows the impact of papers produced by Elham Hatami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elham Hatami. The network helps show where Elham Hatami may publish in the future.
Co-authors
The 25 scholars most cited alongside Elham Hatami, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 141 | |
| 2 | 2020 | 106 | |
| 3 | 2019 | 70 | |
| 4 | 2020 | 57 | |
| 5 | 2018 | 55 | |
| 6 | 2020 | 50 | |
| 7 | 2018 | 47 | |
| 8 | 2020 | 46 | |
| 9 | 2019 | 41 | |
| 10 | 2022 | 21 | |
| 11 | 2018 | 19 | |
| 12 | 2019 | 14 | |
| 13 | 2020 | 13 | |
| 14 | 2022 | 10 | |
| 15 | 2020 | 6 | |
| 16 | 2021 | 1 | |
| 17 | 2012 | 1 | |
| 18 | 2025 | 1 |
About Elham Hatami
Elham Hatami is a scholar working on Cancer Research, Biomaterials, Molecular Biology, Oncology and Plant Science, having authored 18 papers that have together received 699 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (4 papers), Natural Compound Pharmacology Studies (3 papers), Cancer, Lipids, and Metabolism (3 papers), Cancer Treatment and Pharmacology (2 papers), Synthesis of Organic Compounds (2 papers), Extracellular vesicles in disease (2 papers), Carbohydrate Chemistry and Synthesis (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (41 citations), Biomaterials (158 citations), Molecular Medicine (47 citations), Pharmaceutical Science (49 citations) and Biochemistry (42 citations). Elham Hatami has collaborated with scholars based in United States and Iran. Frequent co-authors include Murali Mohan Yallapu, Subhash C. Chauhan, Meena Jaggi, Prashanth K.B. Nagesh, Pallabita Chowdhury, Bilal Bin Hafeez, Sheema Khan, Vivek Kumar Kashyap, Nirnoy Dan and Bernd Meibohm. Their work appears in journals such as Pharmaceutics, Cancers, ACS Applied Materials & Interfaces, ACS Biomaterials Science & Engineering and Cells.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.